• Skip to content
  • skip to navigation
AstraZeneca logo AstraZeneca logo
AstraZeneca logo AstraZeneca logo
  • What science can do
    • What science can do
    • LabTalk blog
    • Our technology
    • Drug modalities
    • Artificial Intelligence
  • Our science
    • Our science
    • Pipeline
    • Publications
    • Cambridge
    • Gothenburg
    • Gaithersburg
  • Our therapy areas
    • All therapy areas
    • Oncology
    • Cardiovascular, Renal and Metabolism
    • Respiratory
    • Other disease areas
    • All medicines
  • Our company
    • Our company
    • Our strategy
    • Our people
    • Leadership team
  • Careers
    • Careers
    • Global careers site
  • Investors
    • Investor Relations (Global) UK flag
    • Investor Relations (Sweden) Swedish flag
    • Stock Exchange announcements
    • Results and presentations
    • Annual Reports
    • Governance
    • Shareholder information
    • Dividend policy
    • Key facts
    • FAQs
    • Debt Investors
    • ADR Programme
  • Partnering
    • Partnering
    • Secrets to successful partnering
    • Get in touch
    • Business mentoring
    • AstraZeneca Exchange
  • Media
    • Media centre
    • Image library
    • Broadcast videos
    • Articles
    • Press Releases
    • Archive
  • Sustainability
    • Sustainability
    • Access to healthcare
    • Environmental protection
    • Ethics and transparency
    • Resources
  • AstraZeneca Websites
  • Global site
LabTalk logo

  • Follow us

    Join in the conversation through Twitter

Get email alerts for new LabTalks

Sign up

Sign up to email alerts

Your email address will only be used to provide you with services from AstraZeneca that you requested. You can opt out for email subscriptions at any time. Your personal information will not be provided to any third party without your permission.

?

AstraZeneca Websites

This website is intended for people seeking information on AstraZeneca's worldwide business. Our country sites can be located in the AZ Network.




Veeva ID: Z4-8411
Date of next review: August 2020

Resources

  • All resources
  • Open Innovation
  • Externally sponsored scientific research
  • US prescription assistance programmes
  • Global clinical trials information
  • Medicines
  • Report a possible side effect
  • Pearl Therapeutics

Quick links

  • Media
  • Investor Relations
  • Partnering
  • Careers
  • Sustainability
  • Modern Slavery Statement
  • Supplier information
  • Social Media Community Guidelines

Social Media

  • LinkedIn
  • Twitter
  • Instagram
  • Glassdoor
  • Facebook

utility links

  • Legal notice and Terms of Use
  • Privacy notice
  • Cookie policy
  • Site map
  • Contact us

© AstraZeneca 2019

You are now leaving AstraZeneca.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.

Cancel Continue
?

Important notice for users

You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.

I disagree I agree
?
?